The global pharmaceutical landscape is witnessing unprecedented developments in blood disorder management, particularly in addressing hypercoagulable conditions that affect diverse patient populations worldwide. As medical understanding deepens and diagnostic capabilities expand, the market for effective anticoagulation solutions continues to evolve at a remarkable pace....